Mostrar el registro sencillo del ítem

Doxycycline en prévention des infections sexuellement transmissibles, pratiques d’utilisation : revue narrative de la littérature

dc.rights.licenseopenen_US
dc.contributor.authorMOUCHE, Liliane
dc.contributor.authorDE GERMAY, Sibylle
IDREF: 25540610X
dc.contributor.authorPERINO, Justine
ORCID: 0000-0003-0039-0734
IDREF: 254309690
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorCAZANAVE, Charles
dc.date.accessioned2025-05-27T07:16:22Z
dc.date.available2025-05-27T07:16:22Z
dc.date.issued2025-01-01
dc.identifier.issn0995-3914en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/206730
dc.description.abstractEnThe off-label use of doxycycline to prevent certain sexually transmitted infections (STIs), outside controlled research environments, has been occurring for several years. The objective of this study was to describe the off-label use of doxycycline as a preventive treatment for STIs by conducting a review of the literature, including analysis of a social network. In total, 11 eligible references were identified, comprising 9 letters and 2 original articles. One press article and six Reddit® discussions were also selected. Most doxycycline users identified in this study were men who have sex with men, with numerous partners and without using condoms. Doxycycline was mainly prescribed by a doctor, but some users obtain the medication in its veterinary form via the internet. HIV PrEP was identified as a factor leading to the decision to take doxycycline. While most users expressed confidence in its efficacy, some expressed reservations due to its inability to provide comprehensive protection against all STIs, and due to the occurrence of side effects. The increase in self-medication with doxycycline for STI prevention necessitates enhanced monitoring, addressing both disease transmission risks and potential adverse drug reactions.
dc.language.isoFRen_US
dc.subject.enDoxycycline
dc.subject.enHumans
dc.subject.enSexually Transmitted Diseases
dc.subject.enAnti-Bacterial Agents
dc.subject.enOff-Label Use
dc.subject.enMale
dc.titleDoxycycline en prévention des infections sexuellement transmissibles, pratiques d’utilisation : revue narrative de la littérature
dc.title.alternativeSante Publiqueen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3917/spub.251.0119en_US
dc.subject.halSciences du Vivant [q-bio]/Microbiologie et Parasitologieen_US
dc.identifier.pubmed40402719en_US
bordeaux.journalSanté Publiqueen_US
bordeaux.page119-129en_US
bordeaux.volume37en_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.issue1en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-05086066
hal.version1
hal.date.transferred2025-05-27T07:16:24Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.title=Doxycycline%20en%20pr%C3%A9vention%20des%20infections%20sexuellement%20transmissibles,%20pratiques%20d%E2%80%99utilisation%20:%20revue%20narrative%20de%20la%20litt%C3%A9r&rft.atitle=Doxycycline%20en%20pr%C3%A9vention%20des%20infections%20sexuellement%20transmissibles,%20pratiques%20d%E2%80%99utilisation%20:%20revue%20narrative%20de%20la%20litt%C3%A9&rft.jtitle=Sant%C3%A9%20Publique&rft.date=2025-01-01&rft.volume=37&rft.issue=1&rft.spage=119-129&rft.epage=119-129&rft.eissn=0995-3914&rft.issn=0995-3914&rft.au=MOUCHE,%20Liliane&DE%20GERMAY,%20Sibylle&PERINO,%20Justine&CAZANAVE,%20Charles&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem